A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human KCNJ14.
Points forts
Amino Acid Sequence
ETEEGNGVETEDGAASPRVLTPTLALTLPP The KCNJ14 Recombinant Protein Antigen is derived from E. coli. The KCNJ14 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-052135 |
|---|
| Réf. fabricant | 18275543 |
|---|
| Gene ID (Entrez) | 3770 |
|---|
| Méthode de purification | >80% by SDS-PAGE and Coomassie blue staining |
|---|
| Nom usuel | KCNJ14 Recombinant Protein Antigen |
|---|
| Contenu et stockage | Store at −20°C. Avoid freeze-thaw cycles |
|---|
| Formule | PBS and 1M Urea, pH 7.4 |
|---|
| À utiliser avec (application) | Blocking/Neutralizing, Control |
|---|
| Alias de gène | ATP-sensitive inward rectifier potassium channel 14, IRK4, KIR2.4, potassium inwardly-rectifying channel, subfamily J, member 14 |
|---|
| Symbole de gène(s) | KCNJ14 |
|---|
| Type d’étiquette | Unlabeled |
|---|
| Type de produit | Recombinant Protein Antigen |
|---|
| Quantité | 100μL |
|---|
| État réglementaire | RUO |
|---|
| Catégorie de recherche | Signal Transduction |
|---|
| Source | E.coli |
|---|
| Réactivité spécifique | This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-50876. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
